LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News REGULATION FLASH L impact Sep 29, 2026, 03:28 PM UTC

JPMorgan CEO Dimon: May Exceed $1.5 Tln Goal For Natl Sec. Initiative

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Russia to cut welfare, education and healthcare funding in 2027 draft budget Fiscal documents show Russia plans lower 2027 spending on welfare, education, healthcare and national economy items to help cover higher military outlays. Defence spending is liste M impact | REGULATION | Sep 29, 2026, 04:26 PM UTC FATF says Canada should strengthen prosecution of complex money laundering The watchdog said Canada struggles to prosecute professional money laundering in standalone cases and should improve risk-based supervision and asset recovery within three years. F M impact | REGULATION | Sep 29, 2026, 04:25 PM UTC BayFirst appoints Robin L. Oliver and Scott J. McKim to revised employment agreements BayFirst entered into revised employment agreements with Executive Vice President & Chief Operating Officer Robin L. Oliver and Executive Vice President & Chief Financial Officer S L impact | REGULATION | Sep 29, 2026, 04:23 PM UTC Fresenius Shares Drop on U.S. Regulator's Warning Letter to Pharma Business By Joshua KirbyShares in Germany's Fresenius closed lower after the U.S. Food and Drug Administration said it alerted the company to what it called serious violations at a U.S. fac L impact | REGULATION | Sep 29, 2026, 04:22 PM UTC AbbVie Stock Drops Although Juvmo Wins Parkinson's Approval AbbVie NYSE:ABBV, the immunology and neuroscience drugmaker, secured FDA approval for Juvmo, a once-daily Parkinson's treatment. Its shares dropped nearly 0.8% to $264.29 at 10.10 L impact | REGULATION | Sep 29, 2026, 04:21 PM UTC Neogen Gets FDA Warning After Probe Links Vet Product to Horse Deaths By Katherine HamiltonNeogen received warning letters from the Food and Drug Administration following an investigation that linked a vet wound care product labeled as sterile to ser L impact | REGULATION | Sep 29, 2026, 04:06 PM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.